Literature DB >> 19556755

Worldwide guidelines for the preparation and quality management of dialysis fluid and their implementation.

Richard A Ward1.   

Abstract

Quality standards for dialysis water have existed for more than 25 years. Current standards generally agree concerning the maximum allowable levels of chemical contaminants; however, significant differences exist concerning the maximum allowable levels of microbiological contaminants and the methods used to measure them. While quality standards for dialysis water are common, there are relatively few standards or recommendations for dialysis fluid quality and these also differ markedly in the maximum allowable level for microbiological contaminants. Compliance with quality standards for dialysis water and dialysis fluid appears to have improved over the past 20 years, although the actual extent of compliance is difficult to assess. A universal standard for fluid quality might be of benefit to the wider dialysis community; however, progress towards that goal will depend on resolution of important issues, including how the standard is to be applied, if it should be limited to substances with documented toxicity for hemodialysis patients, and how to address microbiological contaminants. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556755     DOI: 10.1159/000213489

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  3 in total

1.  Section 5: Dialysis Interventions for Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03

2.  Microbiological qualification of air, water and dialysate in a haemodialysis centre: a new focus on Legionella spp.

Authors:  Saeid Nazemi; Mehdi Mirzaii; Somayeh Yaslianifard; Davood Darban-Sarokhalil; Seyyed Sajjad Khoramrooz; Pirasteh Norozi; Fatemeh Davardoost
Journal:  Iran J Microbiol       Date:  2016-08

3.  Disinfection of the hospital water supply: a hidden risk to dialysis patients.

Authors:  Nicholas A Hoenich
Journal:  Crit Care       Date:  2009-12-01       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.